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Introduction: Controversy persists about the role of VATS lobectomy for
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less often than in the USA or Japan. This article reviews existing data
comparing the results of VATS vs. open lobectomy for the treatment of
lung cancer in order to provide a scientific basis for a rational assess-
ment of this issue.
Methods: The review of the data presented here draws heavily from a
2007metaanalysisbyChengetal.[1]publishedin2007,asitemployed
rigorous methodology in performing a systematic review and metaana-
lysis, and involved a detailed analysis of many major and minor end-
points on an intent to treat basis. This included 36 trials, three of them
randomized, and 3589 patients, reported between 1995 and 2007.
Summary results for individual endpoints are shown as a mean value
with 95% confidence intervals (CI). These values are taken from the
summaryresultsoftheForrestplotsinthesourcearticle.Dichotomized
variablesareexpressedas an OddsRatio,with values<1 being in favor
ofVATSlobectomy.Continuousvariablesarereportedasweightedmean
differences.
Results:TheoperativetimeforaVATSlobectomywasstatisticallylonger,
but only by 16 minutes. The conversion rate from VATS to open was
6%. There was no significant difference in the rates of major bleeding,
blood transfusion or re-operation. VATS lobectomy was associated with
a significantly lower rate of complications in general and pulmonary
complicationsinparticular. Postoperativepainwasreduced,functional
outcomewasbetter,whereasoverallqualityoflifewasnot.Mediastinal
staging was equal with regard to the number of nodes or the number
of nodal stations sampled. The ability of patients to receive adjuvant
chemotherapy was improved following VATS. There was no difference
insurvivalat1and3yearsforlungcancer(allstagescombined).There
was no difference in survival at 5 years for each tumor stage, and no
difference in the rate of deaths at maximal follow-up.
Conclusion: The data suggests that VATS lobectomy for NSCLC is safe,
results in fewer complications, less pain, and more rapid return of nor-
mal functioning. There appears to be either no difference or a slight
benefit in long term survival after VATS lobectomy. These conclusions
are demonstrated by a comprehensive, rigorous metaanalysis of the
controlled clinical trials, but are weakened by the fact that most of the
studies were not randomized. However, because a large randomized
trial is not likely to ever be conducted, this represents the best assess-
ment of the value of VATS lobectomy that is available.
Zusammenfassung
Einführung: An der thorakoskopischen Lobektomie scheiden sich die
Geister, ganz besonders, wenn es um die Therapie des Bronchialkarzi-
noms geht. Diese Kontroverse ist in Europa, wo wesentllich weniger
onkologische VATS (videoassistierte Thorakoskopie)-Lobektomien
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Der vorliegende Artikel möchte eine rationale Bewertung erleichtern,
indemerdieErgebnissederoffenenundthorakoskopischenLobektomie
beiBronchialkarzinomanhandderaktuellenDatenlagegegenüberstellt.
Methoden: Die hier vorgestellte Übersicht lehnt sich an eine 2007 von
Chengetal.[1]publizierteMetaanalysean,diesichdurchihrerigorose
Methodik, die genaue Analyse aller relevanten Endpunkte und die ein-
geschlossene Anzahl von 36 Studien, darunter drei randomisierte, und
3589Patientenauszeichnet.ZurübersichtlichenDarstellungeinzelner
Endpunkte wurde der Mittelwert mit einem 95% Konfidenzinterval (CI)
gewählt; die Werte wurde den Forrest Plots der Quellenartikel entnom-
men. Kategorielle Daten wurden durch Odds Ratios abgebildet, wobei
eine Odds Ratio <1 einen Vorteil für die VATS Lobektomie ausdrückt.
Quantitative Daten wurden als gewichtete Mittelwerte dargestellt.
Ergebnisse:ThorakoskopischeLobektomiendauertenstatistischgese-
hen 16 Minuten länger als offene. Die Konversionsrate betrug 6%.
HinsichtlichderHäufigkeitvonBlutungskomplikationen,Transfusionen
und Revisionseingriffen gab es keine signifikanten Unterschiede. Die
Häufigkeit allgemeiner und pulmonaler Komplikationen war beim tho-
rakoskopischen Vorgehen signifikant geringer. Weitere signifikante
Vorteile zeigte das thorakoskopische Vorgehen bei postoperativen
Schmerzen und funktionellem Ergebnis, allerdings ohne Niederschlag
inLebensqualitätsanalysen.DasintraoperativemediastinaleLymphkno-
tensampling zeigte hinsichtlich Anzahl untersuchter Lymphknoten und
Lymphknotenstationen keinen signifikanten Unterschied. Adjuvante
Chemotherapien sind nach thorakoskopischer Lobektomie besser
durchführbar.ÜberlebennacheinemunddreiJahren(alleTumorstadien)
sowie stadienspezifisches Überleben nach 5 Jahren und maximaler
Beobachtungszeit waren nicht signifikant verschieden.
Schlussfolgerung: Die bisher umfassendste Metaanalyse kontrollierter
klinischer Studien lässt folgende Schlüsse zu: Die thorakoskopische
LobektomiezurBehandlunggeeigneterStadiendesBronchialkarzinoms
istsicherdurchführbarundverursachtimVergleichzumoffenenVorge-
hen weniger Komplikationen, weniger Schmerzen und weniger Funkti-
onseinschränkungen.DasLangzeitüberlebenistderoffenenLobektomie
zumindest gleichwertig. Einerseits darf nicht übersehen werden, daß
in diese Analyse lediglich drei randomisierte Studie eingeschlossen
werdenkonnten.AndererseitsistdieDurchführungeinergroßenrando-
misiertenStudiesehrunwahrscheinlich,sodaßesvernünftigerscheint,
dieErgebnissederMetaanalyseimMomentalsbestmöglicheBewertung
der thorakoskopischen Lobektomie zu akzeptieren.
Introduction
The first lobectomies performed using Video-Assisted
Thoracic Surgery (VATS, also called thoracoscopy) were
reported over 15 years ago [2], [3], [4]. Since then, mul-
tiple large series have been reported, including several
systematic reviews and metaanalyses [1], [5], [6], [7],
[8],[9].Thescopeofwhatcanbesuccessfullyperformed
thoracoscopically includes pneumonectomy [10], [11],
segmentectomy [12], sleeve lobectomy [13], and eso-
phagogastrectomy [14]. However, in the US, VATS lobec-
tomy is done in only about 20% of major academic cen-
ters [15], although in those centers that perform VATS
lobectomythevastmajorityoflungcancerresectionsare
performed thoracoscopically.
Most of the published data on VATS lobectomy involves
institutionalseries,andonlyafewsmallrandomizedtrials
havebeenreported[16],[17],[18].Nolargerandomized
trialcomparingthesetechniqueshaseverbeeninitiated,
and it is highly unlikely that this will ever be done. A ran-
domized trial was under consideration at the National
Institutes of Health in the USA for several years, but after
analysis of the data from phase II studies it was deemed
not to be a worth the effort. This is because outcomes
data for the two approaches were so similar that a trial
would have to include a large number of patients only to
demonstrate equivalence.
Nevertheless,controversypersistsabouttheroleofVATS
lobectomy,particularlyforpatientswithlungcancer.This
is particularly true in Europe, where VATS lobectomy is
performed for lung cancer less often than in the USA or
Japan. This article reviews existing data comparing the
results of VATS vs. open lobectomy for the treatment of
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tional assessment of this issue.
Methods
Thereviewofthedatapresentedheredrawsheavilyfrom
ametaanalysisofreporteddata,whichincludedpublished
and unpublished controlled trials that compared VATS to
open lobectomy for lung cancer [1]. This study [1] offers
a concise review of a large amount of data. Pertinent in-
dividual studies or corroborating studies are cited as
needed. I have chosen to highlight this particular
metaanalysisbecauseitemployedrigorousmethodology
inperformingasystematicreviewandmetaanalysis,and
involved a detailed analysis of many major and minor
endpoints on an intent to treat basis. Many of the indi-
vidualstudiesreportedresultsaccordingtoslightlydiffer-
entdefinitions;however,theauthorsofthismetaanalysis
were able to thoughtfully combine some of the data and
thereby partially overcome this difficulty. Furthermore,
theauthorsachievedagoodcompromisebetweeninclud-
ing only comparable patients or studies, and allowing
some flexibility in order to have a larger amount of data
to analyze (e.g. allowing series that included a limited
number[<20%]ofwedgeresectionsorsegmentectomies,
and allowing series that included a limited number of
patients [<20%] that did not have lung cancer). The
metaanalysis involved 36 trials and 3589 patients, re-
ported between 1995 and 2007. Only 3 of these were
randomized trials, which included a sum total of 205
patients [16], [17], [18]. All of the studies included in the
metaanalysis involved an anatomic lobectomy, with dis-
section and individual division of the arteries, veins and
bronchus [1].
In order to be concise, I have primarily shown summary
resultsforindividualendpointsasameanvaluewith95%
confidence intervals (CI). These values are taken from
the summary results of the more detailed Forrest plots
in the source article [1]. Dichotomized variables are ex-
pressed as an Odds Ratio, with values <1 being in favor
of VATS lobectomy. Continuous variables are reported as
weighted mean differences. The numbers of studies and
patientscontributingtoasummaryendpointareindicated
whenever this data was available.
There were no differences in patient characteristics in
the VATS group vs. the open group in the randomized
studies. However, because most of the studies were not
randomized, there were some significant differences
whenallpatientswereexamined.TheVATSpatientswere
significantly more often women, had smaller and more
often earlier stage tumors, and a higher proportion of
adenocarcinoma. There was no difference in age
(Table 1).
Table1:Baselinecharacteristicsofpatientsincontrolledtrials
Results
Intraoperative outcomes
There is no significant difference in the rates of major
bleeding (>500 ml), blood transfusion or re-operation
(Figure 1). In fact there was a trend to better outcomes
in VATS lobectomy patients (perhaps not statistically sig-
nificant because only a small number of trials reported
this data). Blood loss as a continuous variable was stat-
istically less in VATS lobectomy patients, although the
difference of 80 ml is clinically insignificant. Despite ob-
viatingthetimeneededtoopenandcloseathoracotomy
incision, the operative time for a VATS lobectomy is stat-
istically longer, but only by 16 minutes. Overall, the rate
of conversion from VATS to open among all series re-
portingthisdatawas6%.Otherlargeserieshavereported
conversion rates of approximately 2% [5], [6], with
bleeding accounting for only a minority of conversions.
The need for conversion to an open procedure does not
result in inferior outcomes [19].
Short-term postoperative outcomes
VATS lobectomy is associated with a significantly lower
rateofcomplicationsingeneralandpulmonarycomplica-
tionsinparticularcomparedwithopenlobectomy(Figure
2). There is a trend to a lower rate of pneumonia and
respiratory dysfunction. Other specific complications do
not appear to be different between the two techniques.
There is a strong trend to a higher proportion of patients
withanairleak>7daysamongVATSlobectomypatients.
This appears to be in contradiction to the significantly
shorterhospitalstayanddurationofchesttubedrainage.
This can perhaps be explained by the fact that several
centers performing many VATS lobectomies occasionally
discharge patients to home with a Heimlich valve after
2–3daysifthepatientisotherwisereadytogohomebut
there is still an air leak. This may lead to an increased
proportionofpatientswithachesttubeinplaceat7days
instead of removal at day 5 or 6.
It is important to remember that the majority of included
trials were not randomized, and that there were differ-
encesamongthepatientsthatmayconfoundananalysis
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Bl, blood; CI, confidence interval; Op duratn, operative duration; Re-op, re-operation
Figure 2: Peri-operative complications of VATS vs. open lobectomy
Card, cardiac; CI, confidence interval; Compl, complications; d, days; Hosp. LOS, hospital length of stay; Periop, peri-operative;
Pulm, pulmonary; Resp dysfunctn, respiratory dysfunction
of postoperative complications. Exploratory analyses
however did not suggest that such confounding was oc-
curring. There was no difference in age between VATS vs.
Open lobectomy patients, nor was there a difference in
preoperativeFEV1.Unfortunately,therewasnodatawas
availableregardingtherelativeincidenceofcomorbidities
or on surgeon or center experience.
Postoperative pain is clearly reduced after VATS lobec-
tomy(Figure3),althoughthenumberofcontrolledstudies
reporting pain outcomes was somewhat limited. Signifi-
cantlyfewerpatientsexperiencedseverepainorhadpain
athome,andtherewasatrendtoadecreasedincidence
of any pain. There was a statistically significant lower in-
cidence of pain at 1 year. Postoperative pain was lower
by Visual Analog Scale (VAS) assessment despite a lower
dose, frequency and duration of need for narcotics. Less
pain was seen at early time points, but by 3 months
postoperatively there was no difference.
Functional outcomes are better after VATS lobectomy,
althoughthedataisverylimited(Figure4).Overallquality
of life is not different for VATS vs. open lobectomy. How-
ever, pulmonary function tests at 1 year postoperatively
were better after VATS lobectomy – a time at which full
recovery would seem to have absolved any differences.
Oncologic aspects
Datafromalargenumberofstudieshasshownnodiffer-
enceinmediastinalnodestagingbetweenVATSandopen
lobectomy(Figure5).Thereisnodifferenceinthenumber
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CI, confidence interval; Incid, incidence; Duratn Analg, duration analgesic medication needed; freq, frequency; mo, months; VAS,
Visual Analog Scale pain score; yr, year
Figure 4: Quality of life and functional outcomes of VATS vs. open lobectomy
CI, confidence interval; FEV1, forced expiratory volume in 1 second (post-operative as compared with pre-operative results as %
of normal); FVC, forced vital capacity (post-operative as compared with pre-operative results as % of normal); Indepen func,
independent functioning; Limitatn, limitation; m, months; min, minute; Phys func, physical functioning; QOL, Quality of Life; wk,
week; yr, year; Δ, change (between pre-operative and post-operative results)
of nodes or the number of node stations sampled. This
issue has also been addressed in 2 randomized trials,
which found no difference (although the number of pa-
tients was limited) [16], [17]. The ability of patients to
receive adjuvant chemotherapy is improved following
VATS lobectomy as assessed in only one study [20].
Long-term outcomes
There is no difference in survival at 1 and 3 years
between VATS vs. open lobectomy for lung cancer (all
stagescombined).However,thereisasignificantsurvival
benefit to VATS lobectomy at 5 years and at maximal
follow-up, as demonstrated by a large number of studies
(Figure 6). A strong trend is seen to a lower rate of recur-
rence, consistent with the lower rate of death at maximal
follow-up.However,thisdataisdifficulttointerpret,given
the differences in tumor stage between the 2 groups
(Table 1). Stage specific survival, which neutralizes this
confounding factor, shows no difference for any stage or
subgroup.Furthermore,nosurvivaldifferencewasfound
in the randomized studies. Examination of the long-term
survival curves from the largest series also suggest that
there is minimal, if any difference in survival (Figure 7)
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Adj, adjuvant; Bx’d, biopsied; Chemo, chemotherapy; CI, confidence interval; No., number; reductn, reduction
Figure 6: Long-term outcomes of VATS vs. open lobectomy
CI, confidence interval; max f/u, maximal follow-up; rand, randomized studies; S, survival; Surv, survival; yr, year
Figure 7: Overall survival after VATS lobectomy for lung cancer in 1100 patients
Reproduced with permission from McKenna et al. [5]
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Detterbeck: Thoracoscopic versus open lobectomy debate: the pro ...Figure 8: Overall survival after VATS vs. open lobectomy in clinical stage Ia patients
Reproduced with permission from Sakuraba et al. [21]
[5].Thisiscorroboratedbystagespecificnon-randomized
comparisons (Figure 8) [21].
Technical factors of VATS lobectomy
Detailsoftheincisionmadetoaccomplishathoracoscop-
iclobectomyvarysignificantly.Probablythebiggestaspect
is whether the procedure is done purely by looking at the
video-image without rib-spreading (complete VATS or c-
VATS),orwhetheraribspreaderisusedandtheresection
is accomplished at least partially by looking directly
through this incision (known as assisted VATS or a-VATS).
This issue was also addressed in the Metaanalysis by
Cheng et al. [1]. A c-VATS approach is associated with a
shorter length of hospitalization and less pain compared
with a-VATS (Figure 9). There is no difference in nodal
staging, but longer operative time with c-VATS (by 27
minutes). Additional analyses suggested that the differ-
encesbetweenopenthoracotomyanda-VATSweremuch
less pronounced than when thoracotomy is compared
with c-VATS (data not shown) [1]. Others have also found
benefitstoc-VATS,includingshorterhospitalization,more
rapid return to normal functioning (within days), and re-
duced inflammatory mediators [22]. In aggregate, this
data suggests that the more dramatic benefits of VATS
are seen when rib-spreading is avoided.
Discussion
It has been nearly 2 decades that thoracoscopic lobec-
tomy has been performed and perfected, and a large
amountofdatahasbeenreported.Whentakentogether,
thedatasuggeststhatVATSlobectomyforNSCLCissafe,
results in fewer complications, less pain, and more rapid
return of normal functioning. However, after 3 months
there is no difference in pain, and overall quality of life
is only marginally improved. There is no difference in the
ability to carry out an oncologic operation including re-
moval of mediastinal lymph nodes, and there appears to
be either no difference or a slight benefit in long term
survival after VATS lobectomy. These conclusions are
demonstratedbyacomprehensive,rigorousmetaanalysis
of the controlled clinical trials, but are weakened by the
fact that most of the studies were not randomized. How-
ever,becausealargerandomizedtrialisnotlikelytoever
be conducted, this represents the best assessment of
the value of VATS lobectomy that is available.
Several other reviews have arrived at the same conclu-
sions [7], [8], [9]. In addition, European and North
American clinical guideline committees have reviewed
thedata,andcometotheconclusionthatVATSlobectomy
is a reasonable alternative to open resection [23], [24].
Thus thoracoscopic lobectomy must be regarded as es-
tablished and justified approach, even though it is avail-
able in only a minority of centers.
AcomparisonofthecostofaVATSvs.anopenlobectomy
iscomplicated,becauseitisdependentonmanyfactors,
such as whether or not staplers are used extensively
during open and during VATS resections, whether the
better functional status of the patient actually leads to
earlier discharge from the hospital, and different rules
for health care reimbursement in different countries.
When costs have been compared, it appears that a VATS
resection is approximately 5–20% more expensive [1],
[25],[26].Thismaybeworthwhileifoneconsidersearlier
return to work from a societal perspective, although this
aspect is of limited importance from the perspective of
a physician, a hospital or an insurance carrier.
It is always difficult to learn a new technique, and be
comfortable that one can perform this safely and with
good results. Details of the learning curve have not been
well defined, but it has been suggested that around 50
lobectomies are needed [27]. The volume of lobectomy
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a-VATS, assisted VATS (rib-spreading, with dissection done by direct vision through an incision as well as on a video monitor); CI,
confidence interval; c-VATS, complete VATS (no rib-spreading, dissection done entirely by viewing structures on a video monitor);
Hosp. LOS, hospital length of stay; OR, operating room; VAS/Analg d, Visual Analog Scale pain scores or analgesic days
in a particular surgeon’s practice may not be sufficient
to make it worthwhile to develop these skills, especially
given that most of the benefits are transient (gone after
3 months), and data regarding superior long-term out-
comeswithVATSlobectomymustberegardedassuggest-
ive but not conclusive. However, the data indicates that
condemnation of VATS lobectomy as an unsafe or onco-
logically unsound procedure is not justified.
An approach to learning VATS lobectomy is to use an
anterolateral thoracotomy approach, and then gradually
decrease the size of the incision and the amount of rib
spreading. Although it appears that the benefits of VATS
lobectomy are much more marked with a non-rib
spreading approach, period of limited rib spreading in
order to achieve the skills and comfort needed can cer-
tainly be justified [28]. However, patience and a true
commitment to learning a new technique are required.
Abandonment of VATS lobectomy after 5–10 attempts in
which one does not feel equally comfortable as with an
open approach does not constitute a serious effort at
learning a new technique.
In conclusion, VATS lobectomy has been shown to be
safe, result in fewer complications, less postoperative
pain and more rapid recovery compared with lobectomy
via thoracotomy. There is no difference in the ability to
carry out mediastinal node dissection, and a suggestion
that the ability to administer adjuvant chemotherapy is
improved. Long-term outcomes are at least as good, if
not better after VATS lobectomy as compared with thora-
cotomy. The data demonstrates that the VATS approach
is an appropriate alternative to open thoracotomy in pa-
tients undergoing lobectomy for lung cancer.
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